Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly
Current treatments for chronic hepatitis B virus (HBV) infection are not curative. Here, the authors show that an antifungal drug, ciclopirox, inhibits HBV capsid assembly and synergizes with nucleoside/nucleotide analogs to prevent HBV replication in cells and in a humanized liver mouse model.
Guardado en:
Autores principales: | Jung-Ah Kang, Songwon Kim, Minji Park, Hyun-Jin Park, Jeong-Hyun Kim, Sanghyeok Park, Jeong-Ryul Hwang, Yong-Chul Kim, Yoon Jun Kim, Yuri Cho, Mi Sun Jin, Sung-Gyoo Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c10c1a7e6f104a508eca916208b6abe6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA-365 regulates IL-1β-induced catabolic factor expression by targeting HIF-2α in primary chondrocytes
por: Hyun Sook Hwang, et al.
Publicado: (2017) -
Down-regulation of habenular calcium-dependent secretion activator 2 induces despair-like behavior
por: Hyeijung Yoo, et al.
Publicado: (2021) -
Nonsense-mediated mRNA decay factor UPF1 promotes aggresome formation
por: Yeonkyoung Park, et al.
Publicado: (2020) -
Comparison study of image quality at various radiation doses for CT venography using advanced modeled iterative reconstruction.
por: Jung Han Hwang, et al.
Publicado: (2021) -
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
por: Ki-Tae Hwang, et al.
Publicado: (2021)